The global Commercial Aquaculture Vaccines Market is expected to reach USD 1.16 Biliion by the end of 2032, with a valuation of USD 0.45 Biliion in 2023, according to a report released by Zion Ma...
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA ...
